Medicaid Disenrollment During Unwinding Led to Reduced Access to Chronic Disease Medications for Children and Young Adults

Recent research indicates that the end of certain Medicaid eligibility protections during the COVID-19 pandemic, known as the 'unwinding' process which began in April 2023, has significantly disrupted access to essential medications for children and young adults with chronic health conditions such as depression, schizophrenia, ADHD, asthma, and epilepsy. These medications are crucial in managing symptoms, allowing youths to remain in school or work and improve their quality of life. Interruptions in medication regimens can lead to flare-ups and worsening of health conditions.

The study, conducted by the University of Michigan's Susan B. Meister Child Health Evaluation and Research Center (CHEAR) and colleagues, analyzed prescription data for individuals aged 0 to 25 across the United States, focusing on five classes of medications used for behavioral health, respiratory, and seizure disorders. Findings revealed that young adults aged 19 to 25 living in states experiencing the largest drops in Medicaid enrollment faced higher risks of discontinuing their medications compared to those in states with minimal enrollment declines.

Similarly, children in states with significant reductions in Medicaid or CHIP (Children’s Health Insurance Plan) enrollment experienced more disruptions in therapy, though these disruptions were less consistent than for young adults. The states with the greatest declines in child Medicaid enrollment included Arkansas, Georgia, Idaho, and Texas, whereas states with smaller declines were California, Connecticut, and New York. Notably, children in these states often shifted to private insurance or paid cash for their medications.

The impact on young adults was even more pronounced, with those living in states with over 19% drops in adult Medicaid enrollment more likely to cease filling prescriptions or switch to private coverage or cash payments. These changes threaten to impede effective management of chronic conditions, increasing the risk of health crises, absenteeism, and other adverse outcomes.

These findings carry important implications for current and future health policy, especially amid ongoing debates about Medicaid funding. Dr. Kao-Ping Chua emphasized that rapid disenrollment from Medicaid can detrimentally affect chronic disease management among youths and warned that proposed budget cuts might similarly lead to negative health consequences for vulnerable populations.

Overall, approximately 72 million Americans are now enrolled in Medicaid, along with over 7 million children in CHIP, highlighting the importance of stable healthcare access for managing chronic illnesses. As policymakers evaluate funding and eligibility measures, understanding the repercussions of disenrollment on medication adherence and health outcomes is critical.

Source: Medical Xpress